Preliminary data from the nationwide blood pressure control program in Poland in 2025 — MISSION 50/30

Background: Hypertension remains a leading cardiovascular risk factor globally, with major implications for public health. The Mission 50/30 program, initiated by the Polish Society of Hypertension, aims to improve hypertension management in Poland by achieving blood pressure (BP) control in at least 50% of patients by 2030. This initiative builds upon the International Society of Hypertension’s May Measurement Month (MMM) campaign, addressing persistent gaps in awareness, treatment, and control of hypertension. Material and methods: In 2025, opportunistic BP measurements were conducted across 27 Polish cities, involving 4,829 participants aged ≥ 18 years. Data were collected on demographics, comorbidities, lifestyle, and medication use. Among participants, 47.4% had a prior diagnosis of hypertension, and 84.4% of these reported taking antihypertensive medications. Blood pressure control (< 140/90 mm Hg) was achieved in 53.4% of treated individuals, while only 22.4% met the target of < 130/80 mm Hg. Results: The study revealed that public BP screenings effectively identify individuals with elevated BP, including those unaware of their condition. Compared with the 2021 MMM campaign, the current study population showed a substantially higher proportion of participants with self-reported hypertension, while the percentage receiving antihypertensive treatment remained nearly unchanged. The share of individuals with previously diagnosed hypertension who achieved BP control (< 140/90 mm Hg) increased from 50.6% to 53.4%. The prevalence of self-reported hypertension was comparable to that observed in the 2019 MMM edition; however, in 2019, a higher proportion of hypertensive individuals were receiving treatment and had controlled BP than in the present study. Conclusions: Current findings underscore the importance of sustained public health efforts, standardized measurement protocols, and follow-up assessments to improve hypertension awareness and management.